Episode 3: Mesenchymal stem cells for COVID-19 treatment

Episode 4: Cannabinoid science: Cannabinoids are emerging as a treatment option for autoimmune and other immune-related diseases thanks to their modifications as synthetic derivatives. Emerald Health Pharmaceuticals has widened the potential application of cannabinoids by designing can... by A view on

9 min listen

Episode 3: Mesenchymal stem cells for COVID-19 treatment: Mesoblast CEO Dr. Silviu Itescu speaks to Lonza about the company’s advanced portfolio of anti-inflammatory allogeneic cellular medicines including remestemcel-L, which is currently being evaluated in a U.S. Phase 3 randomized controlled trial for acute ... by A view on

10 min listen

Episode 1: Bioprinting: Scientists have been printing cells for decades, but with the arrival of 3D bioprinters, getting printed tissue models to behave like living tissue has proved elusive. That is why angiogenesis and vascularization are two holy grails of 3D bioprinting. Al... by A view on

8 min listen

Episode 9: Streamlining the cell and gene therapy manufacturing: Delivering Personalized Therapies: Streamlining the Supply Chain for a New Generation of Treatments In this episode, we speak with Amy DuRoss, Co-Founder and Chief Executive Officer of Vineti, about the challenges facing "just-in-time" manufacturing and... by A view on

17 min listen

Episode 7: Microbiome: Bugs as Drugs: Harnessing the Therapeutic Potential of the Microbiome Lukas Schüpbach, the CEO of Bacthera, and Gemma Henderson, Bacthera’s Head of Project and Portfolio Management, speak to Lonza about creating pharmaceuticals from the human microbiome... by A view on

9 min listen

Episode 2: Cell-penetrating peptides for cancer treatment: One of the limitations of cancer therapy is off-target activity, which often has devastating effects on patients’ life quality. A novel strategy pursued by Cybrexa Therapeutics uses treatments specifically targeting solid tumors by taking advantage of on... by A view on

9 min listen

Episode 5: Therapy administration and its safety: In 2016 Lonza established its Drug Product Services (DPS) to realize this supply chain model for its partners and clients. Since then the DPS has grown to a workforce of over 250 experienced experts focused on safety, efficacy and quality. To ensure that... by A view on

10 min listen

Episode 5: Importance of Immunogenicity: De-risking Drug Development: Early Testing for Toxicity Saves Time and Resources Yvette Stallwood, head of Lonza’s Early Development Services, talks about patient safety and other advantages of early testing for immunogenicity in the drug development p... by A view on

19 min listen

Episode 6: Gene editing: Since the arrival of Crispr in 2009, gene editing has made its way into labs. Its groundbreaking importance was acknowledged through the 2020 Nobel Prize in Chemistry. Expanding gene editing for medical treatments, Cellectis focuses its 20 years of exper... by A view on

10 min listen

Episode 3: Antibody Biopolymer Conjugates for Ophthalmology: Bridging Business and Biotechnology: Kodiak Sciences Is Increasing Treatment Efficacy for Retinal Diseases Victor Perlroth, MD, the Chairman and CEO of Kodiak Sciences, discusses how the company’s ABC platform medicines are designed to treat the leading... by A view on

25 min listen

*Repost* Exosomes: In this reposted episode from December 2020, we're exploring how a better understanding of exosomes is leading to new treatments and diagnostic technologies with Uwe Gottschalk. According to Uwe , the exosome revolution is already in full march. As rese... by A view on

12 min listen

Episode 2: Horseshoe crabs and recombinant factor C: Safe Jabs Thanks to Horseshoe Crabs: Making Sure Your Injection is Free of Endotoxins Allen Burgenson, Lonza’s expert for all things testing, speaks to us about the dangers of endotoxin contamination and the future of non-animal testing for it. “Before... by A view on

19 min listen

Episode10: Phage Therapy: Devouring Bacteria: How Phage Therapy Is Shaping Antibacterial Treatments of the Future In this episode we speak with the CEO of BiomX, Jonathan Solomon, about producing and using phages to test and treat various diseases and conditions. Until very rece... by A view on

7 min listen

Episode 1: Oncolytic viruses: A Welcome Virus: Cracking the Viral Code for the Battle Against Cancer Chairman and founder of PsiVac, Prof. Ghassan Alusi, and the chief operating officer, Imad Mardini, discuss how the company’s proprietary oncolytic virus platform offers new hope for ... by A view on

20 min listen

Episode 9: De-risking Drug Development: Where There’s A Risk, There’s A Way: De-risking Drug Development at the Earliest Stages Lonza’s wide array of analytical tools and professional experience create a go-to solution for small biotechs looking to decrease risk in their drug development proce... by A view on

25 min listen

Episode 7: Antibody-Drug Conjugates: Antibody-drug Conjugates: Next-Generation of Targeted Cancer Treatments Iwan Bertholjotti and Laurence Bonnafoux from Lonza give an insider look at how these promising treatments make it from development to commercialization. Chemotherapy is the first-... by A view on

19 min listen

Episode 8: Colors of Capsules: Capsule Manufacturing: It’s Not Only What’s Inside That Counts The recent EU ban on Titanium Dioxide and changing customer habits are shaking up capsule production. Over the past few years, the coloring and manufacturing of pill capsules have undergone ... by A view on

25 min listen

Episode 4: Microbiome: Host and Health: Tailoring Personalized Medicine Using The Unique Microbiome Fingerprint Professor Eran Elinav from the Weizmann Institute of Science discusses how the interaction between the microbiome and its host is transforming personalized medicin... by A view on

7 min listen

Episode 1: A View On Cell Culture Media: Developing Cell Culture Media For Growing Cells We are back! And in the first episode of our new season, we explore growing cells for therapeutic purposes with Lonza specialists Alexis Bossie, Director of Media R&D, and Tariq Haq, Senior Director of ... by A view on

28 min listen

Episode 6: Manufacturing of Exosomes: Putting Manufacturing First: Codiak Moves Swiftly into Clinical Trials with Exosome-based Treatments Sriram Sathyanarayanan, Codiak’s CSO, and Linda Bain, their CFO, share how the company moved into clinical trials in under 6 years. Exosomes, extrem... by A view on

23 min listen

Episode 5: HPAPIs: Lonza experts Selene Araya and Charles Johnson discuss the manufacturing process, trends, and future of highly potent compounds (HPAPIs). They highlight Lonza's facilities and expertise in producing HPAPIs across various technologies and scales, ensu... by A view on

20 min listen

Episode 11: Season 2 Highlights: Join us in celebrating the finale of our second season of A View On, the Lonza podcast. Over the past few months, we have brought you a series of insider conversations with our experts at Lonza, our partners, and leaders in the industry exploring the new... by A view on

14 min listen

Episode 7: Mid-season wrap-up: Season three so far, we’ve covered a lot! In this summary episode, A View On host Martina Hestericova shares a secret and goes over a selection of the best ideas from season three so far. The production team for A View On has managed to keep th... by A view on

14 min listen

Episode 2: A View On Manufacturing Inhaled Drug Products: What If the Jab Were a Puff? A Look at Drug Delivery to the Lungs In this episode we explore the advantages of using inhalers for drug delivery with Lonza experts Kim Shepard and Matt Ferguson. In late 2022, China introduced the world’s first Covid... by A view on

23 min listen

Episode 3: A View On Manufacturing Cell and Gene Therapies: Scaling Up Cell and Gene Therapies: Automation Is the Next Step In this episode, we take a deep dive into manufacturing cell and gene therapies with Lonza expert Behnam Ahmadian Baghbaderani, executive director of Cell and Gene Therapy Process Deve... by A view on

24 min listen

CAR-T Therapies: "A View On: CAR-T Cell Therapies" featuring Tamara Laskowski, Senior Director of Clinical Development in Personalized Medicine at Lonza, and Aya Jakobovits, CEO of Adicet Bio. Dive into the world of CAR-T cells, their therapeutic potential, and the f... by A view on

24 min listen

Episode 10: AI in the Pharma Industry: Artificial Intelligence and Life Sciences: The Dawning of a Digital Revolution in Pharma Manufacturing Dr. Loubna Bouarfa, CEO of OKRA.ai, and Stephan Rosenberger, Lonza's Head of Digital Transformation, discuss how AI is currently transforming the phar... by A view on

27 min listen

Episode 4: A View On Medical Devices: Ian Thomson from Ypsomed and Roman Mathias from Lonza discuss the market trends in injectable delivery devices, their manufacturing process, and their future in sustainable pharma. Injectable devices offer various benefits, including improved conveni... by A view on

27 min listen

*REPOST* Horseshoe crabs and recombinant factor C by A view on

19 min listen

EPISODE 8: A View On Particle Identification: Embark on a microscopic journey into particle identification — the unsung hero of pharmaceutical safety — and uncover how this vital process shields us from unseen threats in every single medication we take. by A view on

25 min listen

Discover this podcast and so much more

Episode 3: Mesenchymal stem cells for COVID-19 treatment

Episode 3: Mesenchymal stem cells for COVID-19 treatment

Description

Titles in the series (32)

More Episodes from A view on

Related podcast episodes